A combination of two Bristol-Myers Squibb immunotherapy drugs cut the risk of death by 37 percent in a key group of kidney cancer patients, data from a closely watched clinical trial showed on Sunday.
Drug Cocktail Cuts Kidney Cancer Death Risk 37 Percent
Comment
Show comments
Hide Comments
